Guillaume Bado

Real-time, portable genome sequencing for Ebola surveillance

Joshua Quick, Nicholas J. Loman, Sophie Duraffour et al. · Nature · 2016 · 1.6K citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 72 citations

Public Health, Community Health, Pharmacotherapy +17

The vulnerability of men to virologic failure during antiretroviral therapy in a public routine clinic in Burkina Faso

Pauline Penot, Arsène Héma, Guillaume Bado et al. · Journal of the International AIDS Society · 2014 · 51 citations · Full text

Public Health, Infectious Diseases, Hiv Control +12

Analysis of the diversity of the HIV‐1 <i>pol</i> gene and drug resistance associated changes among drug‐naïve patients in Burkina Faso

Denis M. Tebit, Lassana Sangaré, Fabrice Tiba et al. · Journal of Medical Virology · 2009 · 32 citations

Life Sciences, Molecular Biology, Molecular Virology +16

Short Communication: High Viral Load and Multidrug Resistance Due to Late Switch to Second-Line Regimens Could Be a Major Obstacle to Reach the 90-90-90 UNAIDS Objectives in Sub-Saharan Africa

Emilande Guichet, Avelin F. Aghokeng, Laetitia Serrano et al. · AIDS Research and Human Retroviruses · 2016 · 31 citations

Life Sciences, Pharmacotherapy, Clinical Pharmacology +16